Related Experiment Video

Updated: Aug 10, 2026

Retrograde Perfusion and Filling of Mouse Coronary Vasculature as Preparation for Micro Computed Tomography Imaging
10:16

Retrograde Perfusion and Filling of Mouse Coronary Vasculature as Preparation for Micro Computed Tomography Imaging

Published on: February 10, 2012

Coronary venous retroperfusion for myocardial revascularization

E B Kay, A Suzuki

    The Annals of Thoracic Surgery
    |March 1, 1975
    PubMed

    Insights

    Retrograde arteriovenous bypass perfusion for coronary artery disease may cause myocardial hemorrhage. A secondary bypass venting the arterial system can prevent this damage, improving outcomes for patients with diffuse occlusive disease.

    Area of Science:

    • Cardiovascular Surgery
    • Experimental Cardiology
    • Myocardial Reperfusion Injury

    Background:

    • Diffuse occlusive coronary artery disease presents challenges for traditional arterial bypass grafting.
    • Retrograde arteriovenous bypass perfusion is a potential alternative for select patients.
    • Concerns exist regarding the safety and efficacy of retrograde perfusion techniques.

    Purpose of the Study:

    • To evaluate the feasibility and potential complications of retrograde arteriovenous bypass perfusion.
    • To investigate the effects of retrograde perfusion on myocardial tissue.
    • To explore methods for mitigating adverse effects associated with retrograde perfusion.

    Main Methods:

    • Experimental models were used to simulate retrograde arteriovenous bypass perfusion.
    • Myocardial tissue was analyzed for signs of hemorrhage and damage.
    • A secondary bypass system was introduced to vent the arterial side to a low-pressure reservoir.

    Main Results:

    • Retrograde perfusion, when opposed to antegrade flow, induced myocardial hemorrhage in experimental subjects.
    • The introduction of a secondary venting bypass successfully prevented hemorrhagic damage to the myocardium.
    • This suggests a potential protective mechanism against perfusion-induced injury.

    Conclusions:

    • Retrograde arteriovenous bypass perfusion carries a risk of myocardial hemorrhage.
    • A secondary venting bypass can mitigate the damaging effects of retrograde perfusion.
    • This strategy may offer a safer approach for managing complex coronary artery disease when antegrade bypass is not feasible.

    More Related Videos

    Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats06:32

    Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

    Published on: June 28, 2019

    Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

    Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

    Published on: May 28, 2019

    Related Concept Videos

    Venous Return01:04

    Venous Return

    The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
    What is Venous Return?
    Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system as it...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    Continuous Renal Replacement Therapy01:30

    Continuous Renal Replacement Therapy

    Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...